posted
there also coming out with a 10 k soon, not sure of the exact date. but they have gone from being in debt for 3 million to up over 1.2 million in 3 months. iv heard from a couple people over at hsm that this quarter should be better then that!
Posts: 89 | Registered: Apr 2006
| IP: Logged |
posted
Let's hope for a gapper and a nice little run today. Had a nice EOD run yesterday.
Posts: 2309 | From: Minnesota | Registered: Feb 2006
| IP: Logged |
posted
Good morning all,I will be away from the computer for most of the day but hopefully be back long before close!!
I like how they lined up each division to compliment each other!
Research Reagents Division
In 2003, we acquired Molecula, LLC, a company in Sterling, Virginia, that sold transfection products. In 2004, we acquired KD Medical, a company in Columbia, Maryland, that supplied research products to more than 300 National Institute of Health (NIH) laboratories, as well as most of the major pharmaceutical companies. While both were generating revenue when acquired, neither was profitable. In the past year, we have worked diligently to make the Research Reagents Division the profitable base we intended.
The first step was to incorporate a new Molecula, Inc. in Nevada, and then combine the operations of Molecula and KD Medical into one facility to more efficiently capitalize on their synergistic operations. Next, marketing efforts were coordinated to take advantage of common markets. Finally, redundancies in the management teams of the two companies were eliminated. The result is that the Research Reagents Division reported a net profit for 2005 and again in the first quarter of 2006. Furthermore, this Division is reporting a 25% growth in revenue for the quarter ended March 31, 2006, as compared to the same period in 2005.
The next move is, literally, a move, into a new location. This Division will be moving into a new facility with two validated Class 100 clean rooms and a complete quality control laboratory that will be used to grow revenues in two different ways. One clean room will be used to increase the manufacturing capabilities of the KD Medical product offerings, so as to manufacture a higher quality of product, and to expand the current custom product offerings to the NIH as well as major universities and pharmaceutical companies. The second clean room will be utilized for other potential growth in revenue by allowing the Division to perform contract research for the many pharmaceutical companies located in this region.
Finally, the Research Reagents Division should also experience growth and greater profitability due to a recent understanding with a large media company to produce some of KD's routine media products. This is intended to allow KD to more aggressively sell these routine products, with greater profitability due to a decrease in redundant labor, and to enter markets that were previously unavailable due to cost competitiveness. This should result in an increase in revenues and allow KD to focus more attention to manufacturing custom products.
In summary, we believe that the Research Reagents Division has become a steady, growing, profitable foundation upon which we can build a greater return for our shareholders.
posted
heres a recap of the S/H letter....any CEO that can boldly make statements like this must KNOW FOR SURE where Calbatech is heading.
the study shows CalbaTech had the second lowest market capitalization. "We believe this means that CalbaTech has tremendous stock upside potential. If our revenues and profits begin to reach pro-forma projections, particularly with LifeStem's Stem Cell MicroBank(TM) Service to open this month, the stock price should respond accordingly," wrote James DeOlden, CEO. The entire letter follows:
Dear Fellow Shareholder:
We at CalbaTech, Inc. thank you for your investment in our Company. The goals at CalbaTech are two-fold: To acquire revenue generating Life Science "tools" companies, that provide products and platforms to researchers, forming a profitable base by which to provide the Company with cash flow and allow it to seek higher reward projects; and to develop those higher reward projects that will provide the opportunity for a greater upside to our shareholders. We believe we are well on our way to accomplishing both of these goals.
Recently, an industry source published information regarding each of the public companies competing in the stem cell arena. Of the sixteen companies listed, CalbaTech was listed third in EBITDA (Earnings Before Income Taxes, Depreciation and Amortization), and first in average daily trading volume, yet had the second lowest market capitalization. We believe this means that CalbaTech has tremendous stock upside potential. If our revenues and profits begin to reach our pro-forma projections, particularly with LifeStem's Stem Cell MicroBank(TM) Service set to open in June, the price of our stock should respond accordingly.
We have put the building blocks in place and have begun building a truly successful company. We are pleased that you have chosen to invest in CalbaTech. Thank you for the trust and continued support.
In 2004, we purchased I-Stem from Dr. Jason R. Van Tassell, M.D. I-Stem owned the intellectual property to the Stem Cell Delivery Device, an endoscopic device capable of delivering adult stem cells directly to infarcted cardiac tissue. Dr. Van Tassel created the concept after hearing about an Illinois teenager who became a cardiac cripple after being shot in the heart by a nail gun. The teenager had adult stem cells injected into his blood stream resulting in cardiac tissue regeneration. While the teenager does not have completely normal cardiac function, the results were significant, allowing him functionality. Dr. Van Tassel reasoned that if stem cells injected into peripheral blood could cause significant cardiac tissue regeneration, then cells injected directly into the cardiac tissue would have even greater efficacy.
Subsequently the Company formed LifeStem, Inc., a wholly-owned subsidiary, to further I-Stem as well as to enter the new emerging field of banking adult stem cells for autologous use. This was determined after canvassing current stem cell banking services and realizing that there was a tremendous void to be filled, as the market had competitors at opposite poles. There are several companies collecting umbilical cord blood from newborns, which contain fertile stem cells, and there are other companies that are collecting autologous stem cells from adults in extremely inconvenient, invasive, costly, and time consuming ways. The former only helps those of the generation being born today whose parents have the foresight to take advantage of storing cord blood, and the latter does not provide non-invasive and convenient collection and storage of adult stem cells at a reasonable price.
We also determined that there were not any companies offering to collect adult stem cells from more than one tissue source. Some stem cells are more likely to develop into blood cells and similarly related tissues, while others are more likely to develop into bone, cartilage or muscle tissue. We therefore developed the process of harvesting stem cells in micro quantities to be cryopreserved for future transplantation into the client. We filed a patent application for our Stem Cell MicroBank(TM) Service, which is promulgated on the belief that it is unnecessary to collect an amount of stem cells sufficient to fully reconstitute one's entire immune system at the time of collection. LifeStem's Adult Stem Cell MicroBank(TM) is the only company to offer "micro" collections of stem cells from two different tissue sources thereby offering greater potential for treatments for multiple diseased conditions.
To a large degree, we believe that the adult stem cell collection and storage market mirrors the cosmetic surgery market, with its emphasis on proactive and preventative healthcare. People likely to have cosmetic surgery are concerned about quality of and longevity of life, they are health conscious, college-educated, and tend to seek non-traditional medical services. To this end, in December 2005, we signed a distribution agreement with Solana MedSpas, a developer and syndicator of medical spas, with 25 medspas currently open and operating and plans for more than 50 additional locations to open during 2006. In accordance with this agreement, adult stem cell collections will be performed at medspa locations using our Stem Cell Microbank(TM) Service. We are also working to contract with physician's offices to carry our Stem Cell MicroBank(TM) Service and believe that cosmetic surgeons, cardiologists, and orthopedists will be excellent distribution sites. With these agreements, we believe we will be ready to make an explosive entry into this marketplace as we perform the first collections in June.
posted
knowing we have a short week next week and already got confirmation of a news release after the fourth I feel confident today to say we see the .05's (maybe before lunch) and I doubt I will be here to see it,gotta roll out by 10:30 for a couple hours.
posted
is the news that will be release after the 4th, the news we been waiting for?
Posts: 1088 | From: Dallas, Texas | Registered: Feb 2006
| IP: Logged |
posted
I believe the news will contain the opening of the Microbank (which is definitely due to open this month) and also some news on projections of the subs based on what we know already and not getting the "NO" as a reply from Paul.....LOL
quote:Originally posted by stocktrader22: I think this thing will stand still at .045 or go down today, but I did get in at .045 as it should be at .05 sometime next week
or by last run scenario could gain 20-30% per day...
Posts: 420 | From: Canada | Registered: Feb 2006
| IP: Logged |
posted
Last run scenario is very different then current scenario. The one thing I like is this thing is slowly creeping up, lots of accumulation without a 100% crazy gain in a day or such.
-------------------- Disclaimer: Not accountable for anything I say Posts: 6266 | Registered: Jun 2004
| IP: Logged |
posted
Crystal ball tell you this? Mine says it will run past .06 today...
quote:Originally posted by stocktrader22: I think this thing will stand still at .045 or go down today, but I did get in at .045 as it should be at .05 sometime next week
quote:Originally posted by stocktrader22: It's a bad sign when people can continually pick up their shares at the bid, that's why it's not moving north.
-------------------- ***********************
It's all in the timing... Posts: 4303 | From: DSA | Registered: Dec 2003
| IP: Logged |
posted
stopped back before I have to roll out....I still feel pretty good about this closing very strong today and for those who know CLBE you already know the best trading time for this stock has ALWAYS been after 2:00pm and into close,thats where we will make our best gains.
also.....
2006 Dates - Unless noted, the following dates are holidays that The NASDAQ Stock Market is closed. January 2 - New Year's Day January 16 - Martin Luther King Jr.'s Birthday February 20 - Presidents' Day April 14 - Good Friday May 29 - Memorial Day July 4 - Independence Day September 4 - Labor Day November 23 - Thanksgiving Day December 25 - Christmas Day
posted
stocktrader....don't be so nervous,this is probably one of the best penny investments in the OTC's right now....remember BIPH when it was in the single digits? This reminds me EXACTLY of that little puppy!
posted
I'm not nervous, there is a lot of accumulation of this stock, I'm just saying today being friday and all we probably will be in the .042-.045 for close
-------------------- Disclaimer: Not accountable for anything I say Posts: 6266 | Registered: Jun 2004
| IP: Logged |
posted
just got back home and see this puppy is winding up tight and looking great on WAY above average volume! I see a decent EOD rally coming thats probably far better then yesterday.
posted
not sure stocktrader....logically even the DT's may hold off an exit today based on the news confirmation for next week and with the short week ahead and shares being so tight we may get a big push up before close.
posted
Seems to be getting some bigger buys starting to trickle in.
-------------------- Before you criticize someone, try walking a mile in their shoes, then when you do, you'll be a mile away and have their shoes. Posts: 1450 | From: TX | Registered: Feb 2006
| IP: Logged |
posted
Don't get your panties in a bunch boys, this will be sitting at .045 range at close. Next week should be nice. Hold for at least another 2-3 trading days.
-------------------- Disclaimer: Not accountable for anything I say Posts: 6266 | Registered: Jun 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
![[Smile]](smile.gif)
